Currently, new drugs targeting Ang and its receptor, TIE signaling, are being developed to treat cancer and aging-associated eye diseases [17,18], as this pathway plays a unique role in regulating vascular stability, remodeling, and angiogenesis [13,14]. This evidence concerns the gene ANG and cancer.